# Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases

> **Open Intelligence Dossier** · First detected: 2026-06-29 17:07 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include TradingView, Endpoints News, statnews.com and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| TradingView | JATT II Acquisition to Merge With Talawar Tx; JATT to Become Subsidiary in SPAC Deal | [Source Link](https://news.google.com/rss/articles/CBMi3gFBVV95cUxQeXdhYV9XOHNCTlhQQUVGVUZUWlBEYWM0Q21OVW5qb1ZHUXh2S3BSU2FsVWRnNEJsV3RIRzZhOGhEWVMxU2hHQ19YZHZ2VUtfVDJxT0VWNEpGbFJxYjBLUHZER2FGS281dl83LVJRbmVSYlZQQm9WNnczRnFOcmhwUjdVQzZmU0lyeEhYVFlCbTNPN01ZWnZVTkRLOHZkN29aRmszUzZDd29yblNEOWJ5Y1ltMTdPUXY5WDJZNE5GaTRTM2FQN3JNQWllSFRVenlaS0gwY205Rmc1VE1iakE?oc=5) |
| Endpoints News | Biotech SPAC deal gets it to Nasdaq; AstraZeneca Phase 3 win in children's bone disease | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxPa2F6WE1oNy1fMEt0Z3F6VEVDUndaeFNmdGtUVjNyUmV4V040RHczM3ZvaE1NSFgtQTFZVTZHdjQ3aDJEbFVhNXl0RmNBcEFkdnhXSGtvODhKd1lLLTNBNXFqTkh3bHRoSm9HYnZsZG5MSElUbzViRXY4MDJHRW13UHpQaWVvVnRXYUxEdlZUN2pKeDEzU0VYLUhWbHJQZHV1?oc=5) |
| statnews.com | Talawar bets bispecific approach can shake up eczema market | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQOGpsc3ZGTXZ2VTNrTnRva2RsaHVGQTdPSkE1TVZsNTlwcWJJOU5FVjZCN1JTMEV0MVdGaVpRbEI0bmN4TUxnZ0YwOGhBSTcwQ2JwZjBDUFB1VnBtYXBleW9lRFEwR1ZQRTZZdWlWQlNDYzhnTkozd1pMcEJZVXFJNkFENmxQZGJhOXFHYjVaZ2pBUzFodEd0Zw?oc=5) |
| Fierce Biotech | 'There's room for multiple winners': Talawar heads to Nasdaq via SPAC deal to bankroll eczema asset | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxPVVpWWlFTbUFfaTRXU2hTVHlkaFExaWk2dEE2MGFzZVNmMzRBcEJFTG5lN25XZXlvVC1FTHRROWQyU3RvWUphUjJSUVVVUXUtOGMxTWJHUUg3QXFGWEZHZ2VYODMwdGFSNmRmckJER2xyai1xYmlIeU9icndIWUIzYW12ZWN5Q1F6X0ZzeFMyZFFqRmpHcjB4dldiYmdMNTBlSlhhcU9jbkZoRVpFS0o5RTJpWXZDdw?oc=5) |
| PR Newswire | Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases | [Source Link](https://news.google.com/rss/articles/CBMigwNBVV95cUxORDN4SDJhNFBBRGgtN1piRFRMZzFENmpJTjNsSlhwaDhVc2o3aEN4dWtUSWhCTlhleFpkbTZrZE5CM0hwLU9JNVI2UXZiWTJjcTJkc1J0WTloOW1WblBuVGVNWDNjVnlrSVBjWHlvRUs0WDJNM0ZsaHNZcnJ6UmxXS0k4TjB5VzZNWFRkdTJXMWxVdENoLURtaFVEeGxoQlU0cG9QdC1CampPUlRvVVIzTXBvRVpRZUVVUFJqOGx1VF9MbFE1VE5qRV9CZ3FpNFlQMGhCSy1VQVZxOGh3anpVaEE2cGUzLU9KenBtbVVNTV9HeHNMeUNleHg5UkRzT2tIeml1eDNmYjBmX0hlb2pXakpYcENubUpTYzljTDN4NkI5bFdNaGt5c1d5amtsR2s5dC1EQWV6R0hoZlUya3VKZ1YybFBFblQyVTVHc1dvTzNNeTZjcXh) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-29/talawar-therapeutics-and-jatt-ii-acquisition-corp-announce-definitive-business*